The use of biologic agents in treatment of patients rheumatoid arthritis or psoriasis is associated with a significant risk of heptatis B flares.
All articles by Debra Hughes, MS
Biologic agents are associated with “significantly higher” risk of hepatitis B virus (HBV) flares than non-biologic disease-modifying antirheumatic drugs (nbDMARDs) among patients with rheumatoid arthritis (RA) or psoriasis.
Opioid use was associated with an increased risk of hospitalizations for serious infections, and was higher with current use at higher daily doses and when using long-acting formulations, data from a case series analysis has shown at IDWeek 2015.
Ian Crozier, MD, has been described as the sickest person ever to survive Ebola Virus Disease, or EVD. Presenting his story as a survivor at IDWeek 2015, he said he was “happy to be here.”
Children treated with gastric acid suppression therapy—particularly, proton pump inhibitors (PPIs)—had significantly higher healthcare- and community-associated Clostridium difficile infection.
Latest News Your top articles for ThursdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses